Knuf Kayla M, Highland Krista B, Houhoulis Kathryn C, McElrath Angela D
Department of Anesthesiology, Brooke Army Medical Center, Fort Sam Houston, TX 78234, USA.
Departments Anesthesiology, Military & Emergency Medicine, & Medicine, Uniformed Services University, Bethesda, MD 20814, USA.
Mil Med. 2025 Apr 23;190(5-6):e1022-e1028. doi: 10.1093/milmed/usaf029.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have become increasingly prevalent and have the potential to delay gastric emptying. The American Society of Anesthesiologists (ASA) released guidance regarding the perioperative management of patients receiving GLP-1 RAs, but it is unclear the extent to which hospitals in the U.S. Military Health System have implemented policies consistent with this guidance.
A questionnaire was sent to active duty anesthesiologists and Certified Registered Nurse Anesthetists (CRNAs) working in the U.S. Military Health System. The questions assessed the presence of institutional GLP-1 RA perioperative policies, adherence to the policy (if applicable), the basis and components of current and recommended future institutional policies, institutional tracking of policy implementation and outcomes, and knowledge, skills, barriers, and continuing medical education goals related to the perioperative management of patients receiving GLP-1 RAs.
The response rate was 32% (N = 265); a little over half of the respondents were anesthesiologists (53%); and respondents' primary practices included over 50 institutions. More than half (54%) indicated that their primary practice location had a GLP-1 RA perioperative policy; 65% of whom indicated that they always followed the policy. In review of practice locations with >1 respondents, there was a lack of perfect agreement across most locations. The most commonly reported basis for the policy was ASA guidance (87%), followed by department leadership (37%). Barriers to any system-wide GLP-1 perioperative management policy included a lack of gastric ultrasound practice and comfort, as well as reported skills and knowledge, pressure not to cancel cases, scheduling problems, and productivity requirements.
Formal policies were reported by most respondents, but inconsistencies within practice locations suggest that local policy implementation could be improved. Commonly reported barriers to future system-wide policy implementation provide data-driven information for system-wide efforts to improve policy success.
胰高血糖素样肽-1受体激动剂(GLP-1 RAs)越来越普遍,并且有可能延迟胃排空。美国麻醉医师协会(ASA)发布了关于接受GLP-1 RAs患者围手术期管理的指南,但尚不清楚美国军事卫生系统中的医院在多大程度上实施了与该指南一致的政策。
向在美国军事卫生系统工作的现役麻醉医师和注册护士麻醉师(CRNAs)发送了一份调查问卷。这些问题评估了机构GLP-1 RA围手术期政策的存在情况、对政策的遵守情况(如适用)、当前和建议的未来机构政策的依据和组成部分、机构对政策实施和结果的跟踪,以及与接受GLP-1 RAs患者围手术期管理相关的知识、技能、障碍和继续医学教育目标。
回复率为32%(N = 265);略超过一半的受访者是麻醉医师(53%);受访者的主要执业机构包括50多个机构。超过一半(54%)的人表示其主要执业地点有GLP-1 RA围手术期政策;其中65%的人表示他们始终遵循该政策。在对有多名受访者的执业地点进行审查时,大多数地点之间缺乏完全一致的情况。该政策最常报告的依据是ASA指南(87%),其次是部门领导(37%)。任何全系统GLP-1围手术期管理政策的障碍包括缺乏胃超声实践和相关技能、报告的技能和知识不足、不取消病例的压力、排班问题以及生产效率要求。
大多数受访者报告了正式政策,但执业地点之间的不一致表明地方政策实施情况有待改善。普遍报告的未来全系统政策实施障碍为全系统提高政策成功率的努力提供了数据驱动的信息。